Top Industry Leaders in the Smokeless Tobacco Treatment Market
Latest Smokeless Tobacco Companies Updates:
Pfizer (US) announced positive results from a Phase 3 clinical trial of its investigational drug Zyban (bupropion) for smokeless tobacco cessation, demonstrating its efficacy in reducing smokeless tobacco use and promoting abstinence.
GlaxoSmithKline (UK) received FDA approval for its nicotine patch, NicoDerm CQ, for smokeless tobacco cessation, expanding treatment options for users seeking to quit.CBT-Solutions (US) launched a new digital therapy program specifically designed for smokeless tobacco cessation, offering online cognitive behavioral therapy modules and support resources.
Quit Genius (UK) partnered with several health organizations to implement its Quit Genius app, a digital smoking and smokeless tobacco cessation program, in community-based settings.
List of Smokeless Tobacco Key companies in the market:
- British American Tobacco PLC (U.K)
- Altria Group, Inc. (U.S.)
- Japan Tobacco, Inc. (Japan)
- Imperial Brands PLC (U.K)
- Swisher International Group, Inc. (U.S.)
- Swedish Match AB (Sweden)
- Dharampal Satyapal Limited (India)